TRIM34 acts with TRIM5 to restrict HIV and SIV capsids
M. Ohainle, K. Kim, S. Keceli, A. Felton, E. M. Campbell, J. Luban, M. Emerman
This study identifies TRIM34 as an HIV-1 capsid-targeting restriction factor that acts with TRIM5alpha to restrict HIV and SIV infection during reverse transcription.
bioRxiv · Oct 30, 2019 · PreprintMicrobiology